Literature DB >> 31071413

Surgery Does Not Improve Survival in Patients With Isolated Severe Tricuspid Regurgitation.

Andrea L Axtell1, Vijeta Bhambhani2, Philicia Moonsamy3, Emma W Healy2, Michael H Picard2, Thoralf M Sundt4, Jason H Wasfy5.   

Abstract

BACKGROUND: Patients with isolated tricuspid regurgitation (TR) in the absence of left-sided valvular dysfunction are often managed nonoperatively.
OBJECTIVES: The purpose of this study was to assess the impact of surgery for isolated TR, comparing survival for isolated severe TR patients who underwent surgery with those who did not.
METHODS: A longitudinal echocardiography database was used to perform a retrospective analysis of 3,276 adult patients with isolated severe TR from November 2001 to March 2016. All-cause mortality for patients who underwent surgery versus those who did not was analyzed in the entire cohort and in a propensity-matched sample. To assess the possibility of immortal time bias, the analysis was performed considering time from diagnosis to surgery as a time-dependent covariate.
RESULTS: Of 3,276 patients with isolated severe TR, 171 (5%) underwent tricuspid valve surgery, including 143 (84%) repairs and 28 (16%) replacements. The remaining 3,105 (95%) patients were medically managed. When considering surgery as a time-dependent covariate in a propensity-matched sample, there was no difference in overall survival between patients who received medical versus surgical therapy (hazard ratio: 1.34; 95% confidence interval: 0.78 to 2.30; p = 0.288). In the subgroup that underwent surgery, there was no difference in survival between tricuspid repair versus replacement (hazard ratio: 1.53; 95% confidence interval: 0.74 to 3.17; p = 0.254).
CONCLUSIONS: In patients with isolated severe TR, surgery is not associated with improved long-term survival compared to medical management alone after accounting for immortal time bias.
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  immortal time bias; isolated severe tricuspid regurgitation; survival analysis

Mesh:

Year:  2019        PMID: 31071413      PMCID: PMC8890054          DOI: 10.1016/j.jacc.2019.04.028

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  28 in total

Review 1.  Immortal time bias in pharmaco-epidemiology.

Authors:  Samy Suissa
Journal:  Am J Epidemiol       Date:  2007-12-03       Impact factor: 4.897

2.  Surgery of post-infarction ventricular septal defect: risk factors for hospital death and long-term results.

Authors:  C Deville; F Fontan; J M Chevalier; F Madonna; A Ebner; P Besse
Journal:  Eur J Cardiothorac Surg       Date:  1991       Impact factor: 4.191

3.  The need for a new tricuspid regurgitation grading scheme.

Authors:  Rebecca T Hahn; Jose L Zamorano
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2017-12-01       Impact factor: 6.875

4.  Eight-year outcomes of tricuspid annuloplasty using autologous pericardial strip for functional tricuspid regurgitation.

Authors:  Byung-Chul Chang; Suk-Won Song; Sak Lee; Kyung-Jong Yoo; Meyun-Shick Kang; Namsik Chung
Journal:  Ann Thorac Surg       Date:  2008-11       Impact factor: 4.330

5.  Cardiac transplantation in man. VI. Prognosis of patients selected for cardiac transplantation.

Authors:  D A Clark; E B Stinson; R B Griepp; J S Schroeder; N E Shumway; D C Harrison
Journal:  Ann Intern Med       Date:  1971-07       Impact factor: 25.391

6.  Impact of tricuspid regurgitation on long-term survival.

Authors:  Jayant Nath; Elyse Foster; Paul A Heidenreich
Journal:  J Am Coll Cardiol       Date:  2004-02-04       Impact factor: 24.094

7.  Prevalence and Outcomes of Isolated Tricuspid Valve Surgery Among Medicare Beneficiaries.

Authors:  Harun Kundi; Jeffrey J Popma; David J Cohen; David C Liu; Roger J Laham; Duane S Pinto; Louis M Chu; Jordan B Strom; Changyu Shen; Robert W Yeh
Journal:  Am J Cardiol       Date:  2018-09-27       Impact factor: 2.778

8.  Contemporary Trends in the Use and Outcomes of Surgical Treatment of Tricuspid Regurgitation.

Authors:  Fahad Alqahtani; Chalak O Berzingi; Sami Aljohani; Mohamad Hijazi; Ahmad Al-Hallak; Mohamad Alkhouli
Journal:  J Am Heart Assoc       Date:  2017-12-22       Impact factor: 5.501

9.  Repair or Replacement for Isolated Tricuspid Valve Pathology? Insights from a Surgical Analysis on Long-Term Survival.

Authors:  Mina Farag; Rawa Arif; Anton Sabashnikov; Mohamed Zeriouh; Aron-Frederik Popov; Arjang Ruhparwar; Bastian Schmack; Pascal M Dohmen; Gábor Szabó; Matthias Karck; Alexander Weymann
Journal:  Med Sci Monit       Date:  2017-02-25

Review 10.  Isolated tricuspid regurgitation: outcomes and therapeutic interventions.

Authors:  Erin A Fender; Chad J Zack; Rick A Nishimura
Journal:  Heart       Date:  2017-12-11       Impact factor: 5.994

View more
  22 in total

1.  Tricuspid valve annuloplasty at the time of mitral valve surgery: is it justified in all cases?

Authors:  Tirone E David
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-12-06

Review 2.  [Current technologies in interventional treatment of tricuspid valve regurgitation].

Authors:  Sebastian Rosch; Philipp Lurz
Journal:  Herz       Date:  2021-08-10       Impact factor: 1.443

Review 3.  Contemporary review in the multi-modality imaging evaluation and management of tricuspid regurgitation.

Authors:  Tom Kai Ming Wang; Shinya Unai; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

Review 4.  Roles of Cardiac Computed Tomography in Guiding Transcatheter Tricuspid Valve Interventions.

Authors:  Habib Layoun; Paul Schoenhagen; Tom Kai Ming Wang; Rishi Puri; Samir R Kapadia; Serge C Harb
Journal:  Curr Cardiol Rep       Date:  2021-07-16       Impact factor: 2.931

5.  Interventional treatment of tricuspid regurgitation : An important innovation in cardiology.

Authors:  Georg Goliasch; Julia Mascherbauer
Journal:  Wien Klin Wochenschr       Date:  2020-02       Impact factor: 1.704

Review 6.  Tricuspid valve regurgitation: current diagnosis and treatment.

Authors:  Robert J Henning
Journal:  Am J Cardiovasc Dis       Date:  2022-02-15

7.  Early surgery can improve the outcomes of patients with severe tricuspid regurgitation undergoing tricuspid replacement.

Authors:  Kun Hua; Rui Zhao; Zhan Peng; Yunxiao Yang; Osmanaj Florian; Bin Mao; Xiubin Yang
Journal:  Cardiovasc Diagn Ther       Date:  2021-10

8.  Live Three-Dimensional Multiplanar Reconstruction Imaging Guidance for Concomitant Mitral and Tricuspid Valve Repairs Using the MitraClip.

Authors:  Tom Kai Ming Wang; Serge C Harb; Rhonda L Miyasaka; John Wagener; Amar Krishnaswamy; Grant K Reed; Samir R Kapadia
Journal:  CASE (Phila)       Date:  2020-02-11

9.  Isolated surgical tricuspid repair versus replacement: meta-analysis of 15 069 patients.

Authors:  Tom Kai Ming Wang; Brian P Griffin; Rhonda Miyasaka; Bo Xu; Zoran B Popovic; Gosta B Pettersson; Alan Marc Gillinov; Milind Y Desai
Journal:  Open Heart       Date:  2020-03-17

Review 10.  Future Perspectives in Percutaneous Treatment of Tricuspid Regurgitation.

Authors:  Antonio Mangieri; Matteo Pagnesi; Damiano Regazzoli; Alessandra Laricchia; Edwin Ho; Ythan Goldberg; Mei Chau; Francesco Gallo; Andrea Fisicaro; Arif Khokhar; Antonio Colombo; Francesco Giannini; Azeem Latib
Journal:  Front Cardiovasc Med       Date:  2020-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.